Nikolay Stoyanov

Nikolay Stoyanov

Auto-generated profile, based on publicly available information

Nikolay Stoyanov

University Hospital Saint Anna Sofia Bulgaria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Bulgarian Cardiology
Verified
Journal Article
Open access
PDF file
PAPetya Angelova
Petya Angelova
NSN. Stoyanov
N. Stoyanov
VVV. Velchev
V. Velchev
SAS. Atemin
S. Atemin
MSM. Sleptsova
M. Sleptsova
ИТИ. Търнев
И. Търнев
Introduction: Cardiomyopathies are a clinically and genetically heterogeneous group of diseases, that are associated with significant morbidity and mortality. The aim of the present study is to clarify the molecular-genetic characteristics of cardiomyopathies in patients in Bulgaria. Material and methods: In the present study, targeted analysis of an expanded panel of 242 genes, associated with cardiomyopathy, and an additional panel of 20 genes, associated with hereditary amyloidosis, was performed in a total of 20 Bulgarian patients, diagnosed with cardiomyopathy, as follows: 12 patients with hypertrophic cardiomyopathy (HCM), including 1 pediatric patient, 6 patients with dilated cardiomyopathy (DCM), of whom 2 pediatric patients, and 2 patients with restrictive cardiomyopathy (RCM). Family segregation analyses were performed by direct Sanger sequencing. Results: Genetic findings were present in 90% of the patients. Pathogenic/likely pathogenic variants were found in 12 of the patients (60%), while genetic findings related to the clinical symptoms were not detected in the RCM patients (10%). Approximately 1/3 of the patients had a family history of sudden cardiac death or cardiomyopathy. Pathogenic/likely pathogenic variants were found in 55% of HCM patients with no family history, in ~67% of HCM patients with family history or with sporadic DCM, and in 100% of DCM patients with a positive family history. A respectively 2,5 and 4-fold higher frequency of truncating variants was found in the study group compared to the reports of around 10% in the literature, both in patients with HCM, and in patients with DCM. Pathogenic/likely pathogenic variants in the MYBPC3 gene (71%) were found with the highest frequency in HCM, while DCM is characterized by a diverse genetic profile, and genetic findings in the NDUFB11 and TAZ genes were associated with severe clinical presentation in pediatric patients in the first postnatal days. Results of segregation analyses were reported in 6 of the affected families. Conclusion: The data from the present study supports the importance of conducted genetic testing and medical-genetic counseling in patients and affected families with cardiomyopathy in Bulgaria

6 November 2025 in JACC: Case Reports
Verified
Journal Article
Open access
DFDzhem Farandzha
Dzhem Farandzha
NSNikolay Stoyanov
Nikolay Stoyanov
VVVasil Velchev
Vasil Velchev
Tricuspid bioprostheses are prone to structural valve degeneration, often requiring complex interventions. Surgical reoperation carries high morbidity and mortality, whereas transcatheter valve-in-valve implantation offers a safer alternative. However, when the tricuspid prosthesis is fluoroscopically invisible, accurate valve positioning becomes challenging. This case series presents 3 such patients successfully treated using a novel adjunctive technique. A coronary guidewire was positioned in the right coronary artery as an anatomical marker for the atrioventricular groove. Balloon pre-dilatation was then performed to delineate the bioprosthetic valve's position, guiding precise deployment of the new valve. All procedures utilized Myval prostheses and were completed without major complications. Post-procedural echocardiography confirmed optimal valve function, low transvalvular gradients, and no residual regurgitation. This reproducible approach of combining RCA guidewire marking with balloon pre-dilatation offers an accurate, low-risk solution for managing fluoroscopically invisible tricuspid prostheses during valve-in-valve implantation.

5 May 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
AIAlfonso Ielasi
Alfonso Ielasi
RCRodolfo Caminiti
Rodolfo Caminiti
AGArturo Giordano
Arturo Giordano
AHAndreas Holzamer
Andreas Holzamer
GVGiampaolo Vetta
Giampaolo Vetta
MTMaurizio Tespili
Maurizio Tespili

4 September 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
EMElisabetta Moscarella
Elisabetta Moscarella
AIAlfonso Ielasi
Alfonso Ielasi
WKWon-Keun Kim
Won-Keun Kim
Rodolfo CaminitiRodolfo Caminiti
Rodolfo Caminiti
MBMarco Barbanti
Marco Barbanti
Azeem LatibAzeem Latib
Azeem Latib

5 June 2020 in Bulgarian Cardiology
Verified
Journal Article
Open access
PDF file
AZAnna Zagorska
Anna Zagorska
DIDesislava Ivanova
Desislava Ivanova
DKDesislava Kostova-Lefterova
Desislava Kostova-Lefterova
FSFilip Simeonov
Filip Simeonov
VGValeri Gelev
Valeri Gelev
ВZВладимир Иванов Anna Zagorska
Владимир Иванов Anna Zagorska
Introduction. Interventional cardiac procedures are often associated with high patient exposure and therefore require special care in protecting patients from radiation-induced effects. Materials and methods. A retrospective study of typical patients’doses was performed in nine hospitals, with a total number of fourteen angiography systems. The typical values for kerma-area product (KAP), cumulative dose (CD) and fluoroscopy time (FT) for two of the most commonly performed procedures - percutaneous coronary intervention (PCI) and coronary arteriography (CA), were calculated and compared with the Bulgarian National Diagnostic Reference Levels (NDRL). Data analysis, regarding the risk of radiation-induced skin effects due to interventional cardiac procedures, was performed. Aim. 1) to present and analyze the typical KAP values for PCI and CA procedures in cardiology departments with high workload and to compare them with the NDRL; 2) to compare the patient doses with the follow-up levels published in Ordinance 2, to identify patients at risk for radiation-induced effects. Results. The results show that typical values for PCI and CA procedures for some of the angiography systems are higher than the NDRL. In all investigated departments there are patients with at least one exceeded follow-up level for PCI. Conclusions. The results show a potential for optimization in the departments with both high or very low typical dose or FT values. No radiation-induced effect was observed in the followed-up group of patients. The introduction of procedure with "Instruction to the patient after an interventional cardiac procedure(s) with greater complexity and a long fluoroscopy time" for patient follow-up and its regular implementation into the routine clinical practice will help for timely diagnosis and treatment of radiation-induced skin effects after cardiac procedures under fluoroscopy control.

31 December 2021 in Bulgarian Cardiology
Verified
Journal Article
Open access
PDF file
EYElena Yordanova
Elena Yordanova
VVVasil Velchev
Vasil Velchev
APArman Postadzhiyan
Arman Postadzhiyan
NSNikolay Stoyanov
Nikolay Stoyanov
BKBlagorodna Karatancheva
Blagorodna Karatancheva
БYБожидар Финков Elena Yordanova
Божидар Финков Elena Yordanova
Besides the standart echcardiografic parameters for mitral stenosis assessment it is necessary to inquire the hemodynamic characteristics as well. The following article describes and illustrates step-by-step the invasive parameters and their significance in the assessment of mitral stenosis in patients who underwent percutaneous balloon mitral valvuloplasty.